Curis (CRIS) Total Liabilities (2010 - 2026)
Curis (CRIS) reported Total Liabilities of $17.0 million for Q1 2026, down 63.04% on a YoY basis from $45.9 million in Q1 2025, and up 17.06% quarter-over-quarter from $14.5 million in Q4 2025.
Curis (CRIS) Total Liabilities (2010 - 2026) Analysis & Trends
Curis has reported Total Liabilities for 17 years, with the latest figure at $17.0 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities fell 63.04% year-over-year to $17.0 million; the trailing twelve-month figure through Mar 2026 stood at $17.0 million (down 63.04% YoY), and the FY2025 full-year result was $14.5 million, down 69.31% from the prior year.
- Total Liabilities for Q1 2026 stood at $17.0 million, up from $14.5 million in the prior quarter.
- The five-year high for Total Liabilities was $67.1 million in Q3 2022, with the low at $14.5 million in Q4 2025.
- Historically, Total Liabilities has averaged $50.6 million across 5 years, with a median of $52.6 million in 2024.
- Annual changes were most pronounced in 2022 — Total Liabilities retreated 2.81% — and 2025, when it tumbled 69.31%.
- Curis' Total Liabilities stood at $62.3 million in 2022, then dropped by 7.52% to $57.6 million in 2023, then declined by 17.96% to $47.3 million in 2024, then plunged by 69.31% to $14.5 million in 2025, then gained by 17.06% to $17.0 million in 2026.
- The last three Total Liabilities figures came in at $17.0 million (Q1 2026), $14.5 million (Q4 2025), and $42.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 19.51 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 10.44 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 137.56 Mn |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | 16.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.98 Mn |
| Dec 31, 2025 | 14.50 Mn |
| Sep 30, 2025 | 42.33 Mn |
| Jun 30, 2025 | 43.22 Mn |
| Mar 31, 2025 | 45.93 Mn |
| Dec 31, 2024 | 47.26 Mn |
| Sep 30, 2024 | 51.21 Mn |
| Jun 30, 2024 | 51.11 Mn |
| Mar 31, 2024 | 52.56 Mn |
| Dec 31, 2023 | 57.61 Mn |
| Sep 30, 2023 | 60.38 Mn |
| Jun 30, 2023 | 58.08 Mn |
| Mar 31, 2023 | 57.95 Mn |
| Dec 31, 2022 | 62.30 Mn |
| Sep 30, 2022 | 67.11 Mn |
| Jun 30, 2022 | 66.79 Mn |
| Mar 31, 2022 | 64.77 Mn |
| Dec 31, 2021 | 71.59 Mn |
| Sep 30, 2021 | 69.18 Mn |
| Jun 30, 2021 | 68.72 Mn |